Article Versions Notes

van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, et al. Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers. 2021; 13(18):4598. https://doi.org/10.3390/cancers13184598

van der Perk, M. E. Madeleine, Linda Broer, Yutaka Yasui, Leslie L. Robison, Melissa M. Hudson, Joop S. E. Laven, Helena J. van der Pal, Wim J. E. Tissing, Birgitta Versluys, Dorine Bresters, and et al. 2021. "Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study" Cancers 13, no. 18: 4598. https://doi.org/10.3390/cancers13184598

van der Perk, M. E. M., Broer, L., Yasui, Y., Robison, L. L., Hudson, M. M., Laven, J. S. E., van der Pal, H. J., Tissing, W. J. E., Versluys, B., Bresters, D., Kaspers, G. J. L., de Vries, A. C. H., Lambalk, C. B., Overbeek, A., Loonen, J. J., Beerendonk, C. C. M., Byrne, J., Berger, C., Clemens, E., ... on behalf of the PanCareLIFE Consortium. (2021). Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers, 13(18), 4598. https://doi.org/10.3390/cancers13184598